Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | VRTXVertex Pharmaceuticals IncFY2025 · Dec |
|---|---|
| Revenue | $12.00B |
| Revenue, yoy | +8.9% |
| Net income | $3.95B |
| Net income, yoy | +838.1% |
| Net margin | 32.9% |
| Free cash flow | $3.19B |
| FCF margin | 26.6% |
| EPS, diluted | $15.32 |
Add another company.